SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
");background-position:center;background-size:19px 19px;background-repeat:no-repeat;background-color:#222;padding:0;width:var(--form-elem-height);height:var(--form-elem-height);font-size:0;}:is(.js-newsletter-wrapper, .newsletter_bar.newsletter-wrapper) .widget__body:has(.response:not(:empty)) :is(.widget__headline, .widget__subheadline, #mc_embed_signup .mc-field-group, #mc_embed_signup input[type="submit"]){display:none;}:is(.grey_newsblock .newsletter-wrapper, .newsletter-wrapper) #mce-responses:has(.response:not(:empty)){grid-row:1 / -1;grid-column:1 / -1;}.newsletter-wrapper .widget__body > .snark-line:has(.response:not(:empty)){grid-column:1 / -1;}:is(.grey_newsblock .newsletter-wrapper, .newsletter-wrapper) :is(.newsletter-campaign:has(.response:not(:empty)), .newsletter-and-social:has(.response:not(:empty))){width:100%;}.newsletter-wrapper .newsletter_bar_col{display:flex;flex-wrap:wrap;justify-content:center;align-items:center;gap:8px 20px;margin:0 auto;}.newsletter-wrapper .newsletter_bar_col .text-element{display:flex;color:var(--shares-color);margin:0 !important;font-weight:400 !important;font-size:16px !important;}.newsletter-wrapper .newsletter_bar_col .whitebar_social{display:flex;gap:12px;width:auto;}.newsletter-wrapper .newsletter_bar_col a{margin:0;background-color:#0000;padding:0;width:32px;height:32px;}.newsletter-wrapper .social_icon:after{display:none;}.newsletter-wrapper .widget article:before, .newsletter-wrapper .widget article:after{display:none;}#sFollow_Block_0_0_1_0_0_0_1{margin:0;}.donation_banner{position:relative;background:#000;}.donation_banner .posts-custom *, .donation_banner .posts-custom :after, .donation_banner .posts-custom :before{margin:0;}.donation_banner .posts-custom .widget{position:absolute;inset:0;}.donation_banner__wrapper{position:relative;z-index:2;pointer-events:none;}.donation_banner .donate_btn{position:relative;z-index:2;}#sSHARED_-_Support_Block_0_0_7_0_0_3_1_0{color:#fff;}#sSHARED_-_Support_Block_0_0_7_0_0_3_1_1{font-weight:normal;}.sticky-sidebar{margin:auto;}@media (min-width: 980px){.main:has(.sticky-sidebar){overflow:visible;}}@media (min-width: 980px){.row:has(.sticky-sidebar){display:flex;overflow:visible;}}@media (min-width: 980px){.sticky-sidebar{position:-webkit-sticky;position:sticky;top:100px;transition:top .3s ease-in-out, position .3s ease-in-out;}}.grey_newsblock .newsletter-wrapper, .newsletter-wrapper, .newsletter-wrapper.sidebar{background:linear-gradient(91deg, #005dc7 28%, #1d63b2 65%, #0353ae 85%);}
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
A new report found that in just six months, Elon Musk's cost-cutting agency wasted more than $21 billion. Other estimates have found that the cuts will cost more than they save in the long run.
The Department of Government Efficiency wasn't so efficient after all. In fact, it was extraordinarily wasteful, according to a Thursday report by the U.S. Senate's investigations subcommittee.
When Elon Musk spent the early part of this year ransacking the federal government, the billionaire promised that his mass layoffs of federal employees, his choking off of critical foreign aid, and his gutting of consumer watchdogs all served a greater purpose: saving the government—and by extension, the American people—money by rooting out waste.
Musk is already known to have wildly exaggerated the amount that his initiative was saving the public. Government spending in 2025 has been higher than previous years despite Musk's dramatic cuts.
Meanwhile, some analyses after the fact have estimated that the initiatives might actually cost taxpayers money in the long run by slashing funds for tax collection and other forms of spending that increase economic activity.
(Graphic: The Brookings Institute, Tracking Federal Expenditures in Real Time)
The staff report released by the office of Sen. Richard Blumenthal (Conn.)—the ranking Democrat on the Senate Homeland Security Permanent Subcommittee on Investigations (PSI)—only focuses on waste by DOGE that can be quantified in the here-and-now. It finds that in just six months of operation, DOGE wasted more than $21 billion.
This comes at "the very same time," Blumenthal said, that "the Trump administration is cutting healthcare, nutrition assistance, and emergency services in the name of 'efficiency' and 'savings,'" via the recently passed "One Big Beautiful Bill Act," which itself is projected to add $3.4 trillion to the federal deficit over the next 10 years.
Blumenthal said his investigation shows that "DOGE was clearly never about efficiency or saving the American taxpayer money."
By far the largest source of waste it identifies comes from Musk's mass layoffs of nearly 200,000 federal employees. In January, he announced the "Deferred Resignation Program" (DRP), which he described as the "fork in the road."
In order to quickly thin the ranks of government, Musk offered federal employees the opportunity to retire early with their benefits and pay through September 30—a deal that around 200,000 took. The Senate report calculates that the government has spent $14.8 billion to pay these employees not to work for eight months.
Roughly another 100,000 employees were also involuntarily fired from their jobs, and had to receive severance pay that amounts to an additional $6.1 billion.
DOGE's funding freezes also resulted in massive waste: freezes on loans for energy utility projects meant that the government lost out on $263 million worth of interest payments and fees. Meanwhile, $110 million worth of food and medicine was left to spoil in warehouses due to the shuttering of the U.S. Agency for International Development (USAID).
While many of these costs are temporary, other studies looking at the long-term effects of DOGE have found that many of the programs it cut also brought in vastly more revenue than they cost to run.
For instance, according to Yale's Budget Lab, DOGE's firing of thousands of Internal Revenue Service (IRS) employees could cost $395 billion in lost revenues over the next decade, and potentially as much as $2.4 trillion if the decrease in enforcement leads to more tax-dodging.
Musk also virtually eliminated the Consumer Financial Protection Bureau (CFPB), which has returned over $26 billion to American consumers since its creation in 2011 while costing a fraction of that amount to run.
Cuts to public health research by the National Institutes of Health (NIH) may also lead to significant costs in the long run. An April study by the University of Maryland found that it could cost the U.S. 68,000 jobs and $16 billion in revenue annually.
Even the $125 million cut from USAID—which the White House has claimed results in "no return for the American people"—is projected to result in nearly $29 billion lost each year by U.S.-based organizations.
Meanwhile, the human costs to these cuts, especially to USAID, have been catastrophic, with hundreds of thousands already dead from preventable diseases in a matter of months, and potentially as many as 14 million by the end of the decade.
As economics writer Maia Mindel summarized in a post on X: "Okay, yeah, so DOGE was illegal and didn't cancel any big-ticket items and also it didn't increase government efficiency and it lied about all its accomplishments and also none of its staff were even remotely qualified. But at least a million Africans died. Take that, libs."
"Trump has nominated unqualified and dangerous people to serve in the most important health positions in the country," said Eagan Kemp, the author of the report for the consumer advocacy group Public Citizen.
The government watchdog group Public Citizen published a report on Tuesday warning that U.S. President Donald Trump's "dangerous health cabal threatens patients, providers, and the programs they rely on."
The report, written by healthcare policy advocate Eagan Kemp, takes aim at several of Trump's appointees to top healthcare posts. Among those highlighted are Secretary of Health and Human Services (HHS) Robert F. Kennedy Jr., Centers for Medicare and Medicaid Services (CMS) head Mehmet Oz, Deputy HHS Secretary Jim O'Neill, and surgeon general nominee Casey Means.
"The first few months of the Trump administration have brought chaos and disaster to an already fragmented and dysfunctional health care system," the report says. "From efforts to make massive cuts to the ACA and Medicare and layoffs of huge numbers of HHS staff across the agency, it is tough to keep up with all the damage being done."
Kennedy, the report says, has aggressively promoted "conspiracy theories and dangerous anti-science views" during his time as HHS secretary.
The report notes Kennedy's fear-mongering about the safety of the highly effective measles vaccine as the U.S. experienced the largest outbreak in recent years, and his purge of credentialed independent experts from the panel that makes national vaccine recommendations in favor of a clique of anti-vaccine activists.
The report also points to Kennedy's decision to de-emphasize research into infectious disease and prescription drugs and his mass firings at other agencies within HHS, including the Food and Drug Administration (FDA) and the National Institutes of Health (NIH).
"With Kennedy taking command of the HHS, Americans are presented lies and disinformation at an unprecedented scale that are capable of unwinding a century of progress on fighting disease and promoting public health," it says.
The report also highlights Oz's efforts to further privatize Medicare by championing Medicare Advantage, which it says "would leave more Americans at the whim of greedy health insurance corporations." It cites one study, which found that since 2007, overpayments to private Medicare providers added up to more than $600 billion, and could amount to another trillion over the next decade.
Additionally, the report cites findings from the Government Accountability Office (GAO) that patients with significant healthcare needs were more likely to drop Medicare Advantage in favor of returning to traditional Medicare, which it says "indicates that these patients were unable to receive necessary care" under the privatized program.
It describes Oz's "massive conflicts of interest," including his six-figure investments in Medicare Advantage providers like UnitedHealth and CVS Health.
"Medicare Advantage plans regularly deny needed care, making it difficult for low-resource hospitals to remain open to serve the public," the report says."If Oz gets his wish of further expanding Medicare Advantage, it will threaten the solvency of many hospitals, particularly rural hospitals currently at risk of closure, as they would struggle to keep their doors open because they wouldn't have the consistent funding they need to continue serving their communities."
O'Neill, who was appointed last month as Kennedy's deputy at HHS, is described as "a long-time venture capital investor with concerning views that reflect his significant financial ties to for-profit biomedical companies," adding that "his interests run counter to [HHS's] public health mandate."
The report notes O'Neill—a staunch libertarian—is opposed to FDA regulations to ensure the safety and efficacy of drugs, which he said "kill a lot of people and provide a lot of harm to the economy."
He has called to eliminate the agency's mandate to ensure that drugs are effective before they are approved for sale. In a 2014 speech to a biotech group, O'Neill said the FDA should "let people start using them, at their own risk."
As an official in the George W. Bush administration's HHS, he also opposed FDA regulations on diagnostic tests that rely on computer algorithms—an even more pressing issue today given the increasing ubiquity of artificial intelligence, including in healthcare.
"While he has a limited public record of comments on health issues broadly," the report says, "his dangerous and misinformed views about the workings of the FDA provide deep cause for concern that he will prioritize ideological and corporate profit considerations over the public health mandate of the department."
Means, Trump's pick for surgeon general—who would be the top authority on public health recommendations—is described as having "little to no managerial experience in the context of government agencies or scientific research."
She does not have an active medical license, and dropped out of her surgical residency. According to colleagues, she did so after coming to believe "that modern medicine is a conspiracy to keep people sick."
A "wellness influencer" in the mold of Kennedy, she has a history of anti-vaccine views and has advocated for getting rid of the Hepatitis B vaccination for babies, which is credited with reducing HBV infection by 68% over a decade after its introduction in 1991. Means has also said that birth control pills are overprescribed, and that they signal a "disrespect of life."
She also stands to potentially profit from her decisions as surgeon general, the report says, since she remains the chief medical officer of a glucose monitoring technology company and has not stepped down from her post despite the possible conflicts of interest.
"The range of unscientific ideas, wellness products, and conspiratorial claims that Means is associated with," the report says, "makes her a potentially dangerous person to serve in a role that requires being a credible health communicator for the country and upholding sound science."
The state of healthcare in the United States, the report says, is about to become more precarious following the passage of the "One Big Beautiful Bill Act," which is projected to result in 10 million people losing their health insurance. Medicare privatization has also accelerated, with hiked rates for Medicare Advantage plans.
"The fact that Trump, Kennedy, and their allies have taken so many dangerous and misguided actions on health in just the early months of the new administration," the report says, "highlights the need for vigilance and strong pushback from anyone who wants a better healthcare system."
The administration paused National Institutes of Health research funding before reversing course hours later amid fierce backlash.
The White House budget office, led by far-right ideologue and Project 2025 architect Russell Vought, temporarily halted National Institutes of Health funding for scientific research on Tuesday before announcing that the pause was lifted hours later, sparking further chaos and confusion at a key agency that's under growing attack from the administration.
The pause, which would have impacted roughly $15 billion in funding for research institutions across the United States, was implemented due to a footnote from Vought's office "in a document that doles out federal funds" to the NIH, according to The Wall Street Journal.
News of the pause, which applied to research grants and contracts, sparked immediate outrage, with Sen. Patty Murray (D-Wash.) warning it underscored the administration's plan to "decimate lifesaving research in this country."
But the Office of Management and Budget (OMB) appears to have reversed course. The Washington Post reported that the agency "releas[ed] the funds later in the day." The Health and Human Services Department, which oversees NIH, pointed to an OMB spokesperson's statement that "the funds were released" after a "programmatic review."
"The chaos and dysfunction of the Trump administration is staggering," Murray said Tuesday. "These people should not be managing a lemonade stand, much less all federal cancer research."
The White House has proposed slashing the NIH's budget by 40% next fiscal year. The nonpartisan Congressional Budget Office said earlier this month that the Trump administration's proposed cuts would "ultimately decrease the number of new drugs coming to market."
Tuesday's pause added to the turmoil at an agency that has already faced mass firings and attempts to slash critical funding.
Over the weekend, Vought described the NIH as "an agency that needs dramatic overhaul." Mother Jones reported earlier this year that the NIH "funded research that helped scientists better understand cystic fibrosis, which led to Vertex Pharmaceuticals developing a cutting-edge treatment" that Vought's daughter benefited from.
The Trump administration's effort to slash NIH funding "means that research into rare diseases, already inadequate, may slow down," the outlet noted.
"Ninety-five percent of rare diseases, unlike cystic fibrosis, have no treatment, according to the National Organization for Rare Disorders, and most organizations lack the budget to fund drug research in partnership with pharmaceutical companies," Mother Jones added.